NCT06049693CompletedPhase 4
Iron Prehabilitation in Endometrial Cancer
Iron Prehabilitation and Perioperative Infectious Diseases of Endometrial Cancer Patients
Source: ClinicalTrials.gov · Last updated 29 Mar 2024
Brief summary (registry, in English)
Endometrial cancer patients often have iron deficiency anemia before surgery, which can be effectively treated with oral iron supplementation. Anemia and blood transfusions have been previously associated with perioperative infectious diseases. In the present study the investigators will evaluate the impact of perioperative iron supplementation on the incidence of perioperative infections.
- Status (registry)
- Completed
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 156 (actual)
- First submitted
- 25 Apr 2023
- Start date
- Jan 2023
- Primary completion date
- Jan 2024
- Lead sponsor
- National and Kapodistrian University of Athens
- Diseases
- Endometrial cancer
- NCT number
- NCT06049693
What you commit to
- Study type: Interventional · Phase 4
- Participants enrolled: 156
- From Jan 2023 to the primary completion date, Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Women with endometrial cancer requiring immediate surgery due to life-threatening hemorrhage
Who the study is looking for
- Women with endometrial cancer enrolled in the surgical list
Age in the registry: 18 years to 79 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| First department of Obstetrics and Gynecology Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.